- Home
- ITOS vs MYN Comparison
ITOS vs MYN Comparison
Compare ITOS & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- MYN
- Stock Information
- Founded
- ITOS 2011
- MYN 1992
- Country
- ITOS United States
- MYN United States
- Employees
- ITOS N/A
- MYN N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- MYN Finance Companies
- Sector
- ITOS Health Care
- MYN Finance
- Exchange
- ITOS Nasdaq
- MYN Nasdaq
- Market Cap
- ITOS 446.6M
- MYN 358.2M
- IPO Year
- ITOS 2020
- MYN N/A
- Fundamental
- Price
- ITOS $10.11
- MYN $9.37
- Analyst Decision
- ITOS Hold
- MYN
- Analyst Count
- ITOS 6
- MYN 0
- Target Price
- ITOS $10.40
- MYN N/A
- AVG Volume (30 Days)
- ITOS 1.6M
- MYN 86.0K
- Earning Date
- ITOS 08-06-2025
- MYN 01-01-0001
- Dividend Yield
- ITOS N/A
- MYN 4.12%
- EPS Growth
- ITOS N/A
- MYN N/A
- EPS
- ITOS N/A
- MYN N/A
- Revenue
- ITOS N/A
- MYN N/A
- Revenue This Year
- ITOS N/A
- MYN N/A
- Revenue Next Year
- ITOS N/A
- MYN N/A
- P/E Ratio
- ITOS N/A
- MYN N/A
- Revenue Growth
- ITOS 177.89
- MYN N/A
- 52 Week Low
- ITOS $4.80
- MYN $8.47
- 52 Week High
- ITOS $18.13
- MYN $10.62
- Technical
- Relative Strength Index (RSI)
- ITOS 53.14
- MYN 50.46
- Support Level
- ITOS $10.08
- MYN $9.12
- Resistance Level
- ITOS $10.17
- MYN $9.47
- Average True Range (ATR)
- ITOS 0.04
- MYN 0.08
- MACD
- ITOS -0.02
- MYN 0.02
- Stochastic Oscillator
- ITOS 35.29
- MYN 69.44
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock
Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.